We are live on ! Find out more
AC

Ascend Capital Portfolio holdings

AUM $1.99B
1-Year Est. Return 10.36%
This Fund
S&P 500
This Quarter Est. Return
+5.31%
1 Year Est. Return
+10.36%
3 Year Est. Return
+56.79%
5 Year Est. Return
+86.43%
10 Year Est. Return
–
AUM
$2.66B
AUM Growth
+$11.4M
Cap. Flow
-$365M
Cap. Flow %
-13.71%
Top 10 Hldgs %
23.28%
Holding
276
New
116
Increased
46
Reduced
39
Closed
64

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$73.4M
2
WCN
Waste Connections
WCN
+$43.4M
3
MIC
Macquarie Infrastructure Holdings, LLC
MIC
+$39.5M
4
AET
Aetna Inc
AET
+$38.9M
5
FANG icon
Diamondback Energy
FANG
+$33.5M

Top Sells

Rank Stock Value
1
LVNTA
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
+$115M
2
PBYI icon
Puma Biotechnology
PBYI
+$65.5M
3
PRU icon
Prudential Financial
PRU
+$64M
4
HST icon
Host Hotels & Resorts
HST
+$61M
5
AMZN icon
Amazon
AMZN
+$47M

Sector Composition

Rank Sector Weight
1 Healthcare 14.44%
2 Technology 12.23%
3 Energy 11.54%
4 Consumer Discretionary 11.15%
5 Industrials 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNCE
251
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
– –
-180,629
Closed -$2.81M
FRC
252
DELISTED
First Republic Bank
FRC
– –
-4,358
Closed -$454K
CLVS
253
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-92,716
Closed -$7.64M
GBT
254
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-441,674
Closed -$13.7M
ALXN
255
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-39,210
Closed -$5.5M
STAY
256
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
– –
-1,879,046
Closed -$37.6M
FPRX
257
DELISTED
Five Prime Therapeutics, Inc.
FPRX
– –
-50,630
Closed -$2.07M
OXFD
258
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
– –
-51,655
Closed -$868K
PE
259
DELISTED
PARSLEY ENERGY INC
PE
– –
-969,270
Closed -$25.5M
DNKN
260
DELISTED
Dunkin' Brands Group, Inc.
DNKN
– –
-154,379
Closed -$8.19M
MNK
261
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-58,999
Closed -$2.2M
DATA
262
DELISTED
Tableau Software, Inc.
DATA
– –
-143,150
Closed -$10.7M
MON
263
DELISTED
Monsanto Co
MON
– –
-188,461
Closed -$22.6M
AVXS
264
DELISTED
AveXis, Inc. Common Stock
AVXS
– –
-76,938
Closed -$7.44M
LVNTA
265
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
– –
-2,002,110
Closed -$115M
CQH
266
DELISTED
Cheniere Energy Partners LP Holdings LLC
CQH
– –
-102,733
Closed -$2.58M
7 8 9 10
11

Similar funds

MWAC
Mariner Wealth Advisors (Cincinnati) Cincinnati, Ohio $1.81B AUM 13.11% 1-Year Est. Return
TP
Tesuji Partners Fort Lee, New Jersey $1.73B AUM 3.93% 1-Year Est. Return
PC
Pomelo Capital New York $1.04B AUM 1.25% 1-Year Est. Return
RW
Rand Wealth Baltimore, Maryland $893M AUM 9.85% 1-Year Est. Return
TBC
Three Bays Capital Boston, Massachusetts $848M AUM 7.41% 1-Year Est. Return
BWCA
Brenner West Capital Advisors New York $804M AUM 16.19% 1-Year Est. Return
AC
AFAM Capital Austin, Texas $718M AUM 12.09% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Ascend Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Ascend Capital held 276 positions worth $2.66B, up 0.43% from $2.65B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ascend Capital withdrew a net $365M in Q4 2017, closing 64 positions and reducing 39 holdings. Its most notable exit was Liberty Interactive Corporation Series A Liberty Ventures, an estimated $115M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Technology and Energy.

Against the trend, Ascend Capital opened a new position in CVS Health worth $73.2M.

  • Ascend Capital's largest Q4 2017 buy was CVS Health: 1,009,152 shares worth $73.2M.
  • Ascend Capital added most to Waste Connections in Q4 2017, an estimated $43.4M increase.
  • Ascend Capital's biggest Q4 2017 reduction was Puma Biotechnology, cutting an estimated $65.5M.
  • Ascend Capital fully exited Liberty Interactive Corporation Series A Liberty Ventures in Q4 2017, selling an estimated $115M.
  • Ascend Capital's ten largest holdings make up 23% of its $2.66B portfolio in Q4 2017.
  • Ascend Capital opened 116 new positions and closed 64 in Q4 2017.
  • Ascend Capital's portfolio value rose 0.43% quarter-over-quarter to $2.66B.

Based on Ascend Capital's 13F filing for Q4 2017, filed 13 Feb 2018.